Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA), a clinical-stage biotechnology company developing small-molecule therapies for viral infections and immunological diseases, announced that...
The post Enanta Pharmaceuticals CEO Jay R. Luly to Retire in February 2027 After 23 Years; Tara Kieffer Named COO appeared first on citybiz.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.